Article(id=1330225369866678857, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225302346773381, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.04.019, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1624464000000, receivedDateStr=2021-06-24, revisedDate=1644249600000, revisedDateStr=2022-02-08, acceptedDate=null, acceptedDateStr=null, onlineDate=1795080042568, onlineDateStr=2026-11-19, pubDate=1649520000000, pubDateStr=2022-04-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795080042568, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795080042568, creator=13701087609, updateTime=1795080042568, updator=13701087609, issue=Issue{id=1330225302346773381, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='4', pageStart='347', pageEnd='484', issueExtLink='null', onlineDate='null', pubDate='1649520000000', pubDateStr='2022-04-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795080026470, creator='13701087609', updateTime=1795084707533, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330244936621994666, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225302346773381, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330244936621994667, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225302346773381, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=470, endPage=475, ext={EN=ArticleExt(id=1330225370084782666, articleId=1330225369866678857, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Drug therapy and research progress of Alzheimer's disease, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Alzheimer's disease (AD) is a progressive central neurodegenerative disease, which is prevalent in the elderly. In recent years, with the increasing elderly population and the increasing number of AD patients, the prevention and treatment of AD is extremely urgent. However, most of the drugs in clinical use can only alleviate symptoms, and drugs aimed at further improvement are being developed. This article reviewed the current status and research and development of AD drugs, in order to provide reference for clinical treatment..

, authors=Shuqing LIU1, 2, Fenghua GU1, 2, *, authorsList=Shuqing LIU, Fenghua GU, authorCompany=null, correspAuthors=Fenghua GU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330225370328052299, articleId=1330225369866678857, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=阿尔茨海默病的药物治疗及研发进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

阿尔茨海默病(Alzheimer's disease,AD)是一种进行性中枢神经退化性疾病,高发于老年人群。近年来,随着老年人口不断增加,AD患者数量日益增长,其防治迫在眉睫。然而目前临床应用的大多数药物仅能缓解症状,旨在改善病情的药物尚在研发中。该文就现有AD治疗药物和研发现状进行综述,以期为临床治疗提供借鉴。

, authors=刘淑青1, 2, 顾丰华1, 2, *, authorsList=刘淑青, 顾丰华, authorCompany=null, correspAuthors=顾丰华, authorNote=

刘淑青,硕士研究生,研究方向:神经精神药理。

, correspAuthorsNote=
顾丰华,副研究员,研究方向:神经精神药理。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=xsff+rxlNWKj6VVP/14BLg==, magXml=57Bfsl8hgzA/6gjxkmXiNQ==, pdfUrl=null, pdf=9Nuoz553ZfWkBTj7MVDWvw==, pdfFileSize=1712508, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=f0eAHf3SwQBftEi7G8y+vg==, mapNumber=null, fund=null)}, authors=[Author(id=1330225370709733971, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225370797814358, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, authorId=1330225370709733971, language=EN, stringName=Shuqing LIU, firstName=Shuqing, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225370869117527, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, authorId=1330225370709733971, language=CN, stringName=刘淑青, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
2.上海市生物物质成药性评价技术服务平台,上海 200437, bio={"content":"

刘淑青,硕士研究生,研究方向:神经精神药理。

"}, bioImg=null, bioContent=

刘淑青,硕士研究生,研究方向:神经精神药理。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225370533573196, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, xref=1., ext=[AuthorCompanyExt(id=1330225370541961805, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370533573196, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225370550350414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370533573196, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1330225370638430799, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, xref=2., ext=[AuthorCompanyExt(id=1330225370646819408, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370638430799, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1330225370651013713, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370638430799, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市生物物质成药性评价技术服务平台,上海 200437)])]), Author(id=1330225372492313179, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225372592976478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, authorId=1330225372492313179, language=EN, stringName=Fenghua GU, firstName=Fenghua, middleName=null, lastName=GU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225372668473952, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, authorId=1330225372492313179, language=CN, stringName=顾丰华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
2.上海市生物物质成药性评价技术服务平台,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225370533573196, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, xref=1., ext=[AuthorCompanyExt(id=1330225370541961805, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370533573196, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225370550350414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370533573196, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1330225370638430799, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, xref=2., ext=[AuthorCompanyExt(id=1330225370646819408, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370638430799, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1330225370651013713, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370638430799, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市生物物质成药性评价技术服务平台,上海 200437)])])], keywords=[Keyword(id=1330225372777525857, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, language=EN, orderNo=1, keyword=Alzheimer's disease), Keyword(id=1330225372861411938, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, language=EN, orderNo=2, keyword=drug treatment), Keyword(id=1330225372928520803, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, language=EN, orderNo=3, keyword=the new target), Keyword(id=1330225372995629668, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, language=CN, orderNo=1, keyword=阿尔茨海默病), Keyword(id=1330225373066932837, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, language=CN, orderNo=2, keyword=药物治疗), Keyword(id=1330225373125653094, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, language=CN, orderNo=3, keyword=新靶点)], refs=[Reference(id=1330225373205344871, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Tezel G, Timur SS, Bozkurt İ, et al. A snapshot on the current status of Alzheimer's disease, treatment perspectives, in-vitro and in-vivo research studies and future opportunities[J]. Chem Pharm Bull (Tokyo), 2019, 67(10): 1030-1041., articleTitle=null, refAbstract=null), Reference(id=1330225373264065128, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=王英全, 梁景宏, 贾瑞霞, 等. 2020—2050年中国阿尔茨海默病患病情况预测研究[J]. 阿尔茨海默病及相关病, 2019, 2(1): 289-298., articleTitle=null, refAbstract=null), Reference(id=1330225373326979689, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Ramachandran AK, Das S, Joseph A, et al. Neurodegenerative pathways in Alzheimer's disease: a review[J]. Curr Neuropharmacol, 2021, 19(5): 679-692., articleTitle=null, refAbstract=null), Reference(id=1330225373385699946, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Decker AL, Duncan K. Acetylcholine and the complex interdependence of memory and attention[J]. Curr Opin Behav Sci, 2020, 32(1): 21-28., articleTitle=null, refAbstract=null), Reference(id=1330225373465391725, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Ghosh S, Jana K, Ganguly B. Revealing the mechanistic pathway of cholinergic inhibition of Alzheimer's disease by donepezil: a metadynamics simulation study[J]. Phys Chem Chem Phys, 2019, 21(25): 13578-13589., articleTitle=null, refAbstract=null), Reference(id=1330225373545083502, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang R, Reddy PH. Role of glutamate and NMDA receptors in Alzheimer's disease[J]. J Alzheimers Dis, 2017, 57(4): 1041-1048., articleTitle=null, refAbstract=null), Reference(id=1330225373607998063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Bordji K, Becerril-Ortega J, Buisson A. Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer's disease[J]. Rev Neurosci, 2011, 22(3): 285-294., articleTitle=null, refAbstract=null), Reference(id=1330225373687689840, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Kishi T. Matsunaga S, Oya K, et al. Memantine for Alzheimer's disease: an updated systematic review and meta-analysis[J]. J Alzheimers Dis, 2017, 60(2): 401-425., articleTitle=null, refAbstract=null), Reference(id=1330225373754798705, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Newcombe EA, Camats-Perna J, Silva ML, et al. Inflammation: the link between comorbidities, genetics, and Alzheimer's disease[J]. J Neuroinflammation, 2018, 15(1): 276., articleTitle=null, refAbstract=null), Reference(id=1330225373817713266, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Maphis N, Xu G, Kokiko-Cochran ON, et al. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain[J]. Brain, 2015, 138(Pt 6): 1738-1755., articleTitle=null, refAbstract=null), Reference(id=1330225373880627827, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Villarejo-Galende A, González-Sánchez M, Blanco-Palmero VA, et al. Non-steroidal anti-inflammatory drugs as candidates for the prevention or treatment of Alzheimer's disease: do they still have a role?[J]. Curr Alzheimer Res, 2020, 17(11): 1013-1022., articleTitle=null, refAbstract=null), Reference(id=1330225373943542388, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Ozben T, Ozben S. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease[J]. Clin Biochem, 2019, 72: 87-89., articleTitle=null, refAbstract=null), Reference(id=1330225374010651253, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Cioffi F, Adam RHI, Broersen K. Molecular mechanisms and genetics of oxidative stress in Alzheimer's disease[J]. J Alzheimers Dis, 2019, 72(4): 981-1017., articleTitle=null, refAbstract=null), Reference(id=1330225374069371510, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Tönnies E, Trushina E. Oxidative stress, synaptic dysfunction, and Alzheimer's disease[J]. J Alzheimers Dis, 2017, 57(4): 1105-1121., articleTitle=null, refAbstract=null), Reference(id=1330225374140674679, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Ahmad W, Ijaz B, Shabbiri K. Oxidative toxicity in diabetes and Alzheimer's disease: mechanisms behind ROS/RNS generation[J]. J Biomed Sci, 2017, 24(1): 76., articleTitle=null, refAbstract=null), Reference(id=1330225374203589240, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Schipper HM, Song W, Tavitian A, et al. The sinister face of heme oxygenase-1 in brain aging and disease[J]. Prog Neurobiol, 2019, 172: 40-70., articleTitle=null, refAbstract=null), Reference(id=1330225374270698105, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Cheignon C, Tomas M, Bonnefont-Rousselot D, et al. Oxidative stress and the amyloid β peptide in Alzheimer's disease[J]. Redox Biol, 2018, 14: 450-464., articleTitle=null, refAbstract=null), Reference(id=1330225374329418362, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Simunkova M, Alwasel SH, Alhazza IM, et al. Management of oxidative stress and other pathologies in Alzheimer's disease[J]. Arch Toxicol, 2019, 93(9): 2491-2513., articleTitle=null, refAbstract=null), Reference(id=1330225374400721531, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Daulatzai MA. Pharmacotherpy and Alzheimer's Disease: the M-drugs (melatonin, minocycline, modafinil, and memantine) approach[J]. Curr Pharm Des, 2016, 22(16): 2411-2430., articleTitle=null, refAbstract=null), Reference(id=1330225374459441788, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Yoo JM, Lee BD, Sok DE, et al. Neuroprotective action of N-acetyl serotonin in oxidative stress-induced apoptosis through the activation of both TrkB/CREB/BDNF pathway and Akt/Nrf2/Antioxidant enzyme in neuronal cells[J]. Redox Biol, 2017, 11: 592-599., articleTitle=null, refAbstract=null), Reference(id=1330225374543327869, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Uddin MS, Rahma MM, Jakaria M, et al. Estrogen signaling in Alzheimer's disease: molecular insights and therapeutic targets for Alzheimer's dementia[J]. Mol Neurobiol, 2020, 57(6): 2654-2670., articleTitle=null, refAbstract=null), Reference(id=1330225374597853822, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Scheyer O, Rahman A, Hristov H, et al. Female sex and Alzheimer's risk: the menopause connection[J]. J Prev Alzheimers Dis, 2018, 5(4): 225-230., articleTitle=null, refAbstract=null), Reference(id=1330225374652379775, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Viña J, Lloret A. Why women have more Alzheimer's disease than men: gender and mitochondrial toxicity of amyloid-β peptide[J]. J Alzheimers Dis, 2010, 20(Suppl 2): S527-S533., articleTitle=null, refAbstract=null), Reference(id=1330225374715294336, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Bagit A, Hayward GC, MacPherson REK. Exercise and estrogen: common pathways in Alzheimer's disease pathology[J]. Am J Physiol Endocrinol Metab, 2021, 321(1): E164-E168., articleTitle=null, refAbstract=null), Reference(id=1330225374790791809, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Ding XW, Li R, Geetha T, et al. Nerve growth factor in metabolic complications and Alzheimer's disease: physiology and therapeutic potential[J]. Biochim Biophys Acta Mol Basis Dis, 2020, 1866(10): 165858., articleTitle=null, refAbstract=null), Reference(id=1330225374853706370, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Mufso EJ, Counts SE, Ginsberg SD, et al. Nerve growth factor pathobiology during the progression of Alzheimer's disease[J]. Front Neurosci, 2019, 13: 533., articleTitle=null, refAbstract=null), Reference(id=1330225374916620931, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Canu N, Amadoro G, Triaca V, et al. The intersection of NGF/TrkA signaling and amyloid precursor protein processing in Alzheimer's disease neuropathology[J]. Int J Mol Sci, 2017, 18(6): 1319., articleTitle=null, refAbstract=null), Reference(id=1330225374975341188, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Budni J, Bellettini-Santos T, Mina F, et al. The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease[J]. Aging Dis, 2015, 6(5): 331-341., articleTitle=null, refAbstract=null), Reference(id=1330225375034061445, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Mitra S, Behbahani H, Eriksdotter M. Innovative therapy for Alzheimer's disease-with focus on biodelivery of NGF[J]. Front Neurosci, 2019, 13: 38., articleTitle=null, refAbstract=null), Reference(id=1330225375101170310, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Verkhratsky A. Astroglial calcium signaling in aging and Alzheimer's disease[J]. Cold Spring Harb Perspect Biol, 2019, 11(7): a035188., articleTitle=null, refAbstract=null), Reference(id=1330225375176667783, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Sushma, Mondal AC. Role of GPCR signaling and calcium dysregulation in Alzheimer's disease[J]. Mol Cell Neurosci, 2019, 101: 103414., articleTitle=null, refAbstract=null), Reference(id=1330225375252165256, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Thuraisingham RA. Pathogenesis of Alzheimer's disease examined using a modified Puri-Li model that incorporates calcium ion homeostasis[J]. J Mol Neurosci, 2018, 65(2): 119-126., articleTitle=null, refAbstract=null), Reference(id=1330225375319274121, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Verkhratsky A, Rodríguez-Arellano JJ, Parpura V, et al. Astroglial calcium signalling in Alzheimer's disease[J]. Biochem Biophys Res Commun, 2017, 483(4): 1005-1012., articleTitle=null, refAbstract=null), Reference(id=1330225376925692557, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Popović N, Morales-Delgado N, Mena DV, et al. Verapamil and Alzheimer's disease: past, present, and future[J]. Front Pharmacol, 2020, 11: 562., articleTitle=null, refAbstract=null), Reference(id=1330225377022161550, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Tadic M, Cuspidi C, Hering D. Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden[J]. Bio Med Central Cardiovascular Disorders, 2016, 16(1): 208., articleTitle=null, refAbstract=null), Reference(id=1330225377089270415, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Jiang C, Li G, Huang P, et al. The gut microbiota and Alzheimer's disease[J]. J Alzheimers Dis, 2017, 58(1): 1-15., articleTitle=null, refAbstract=null), Reference(id=1330225377156379280, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Cryan JF, O'Riordan KJ, Cowan CSM, et al. The microbiota-gut-brain axis[J]. Physiol Rev, 2019, 99(4): 1877-2013., articleTitle=null, refAbstract=null), Reference(id=1330225377231876753, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=Angelucci F, Cechova K, Amlerova J, et al. Antibiotics, gut microbiota, and Alzheimer's disease[J]. J Neuroinflammation, 2019, 16(1): 108., articleTitle=null, refAbstract=null), Reference(id=1330225377315762834, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang X, Sun G, Feng T, et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression[J]. Cell Res, 2019, 29(10): 787-803., articleTitle=null, refAbstract=null), Reference(id=1330225377387066003, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=Tiwari S, Atluri V, Kaushik A, et al. Alzheimer's disease: pathogenesis, diagnostics, and therapeutics[J]. Int J Nanomedicine, 2019, 14: 5541-5554., articleTitle=null, refAbstract=null), Reference(id=1330225377466757780, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=Yuan XZ, Sun S, Tan CC, et al. The role of ADAM10 in Alzheimer's disease[J]. J Alzheimers Dis, 2017, 58(2): 303-322., articleTitle=null, refAbstract=null), Reference(id=1330225377546449557, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=Moussa-Pacha NM, Abdin SM, Omar HA, et al. BACE1 inhibitors: current status and future directions in treating Alzheimer's disease[J]. Med Res Rev, 2020, 40(1): 339-384., articleTitle=null, refAbstract=null), Reference(id=1330225377605169814, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=Sun BL, Li WW, Zhu C, et al. Clinical research on Alzheimer's disease: progress and perspectives[J]. Neurosci Bull, 2018, 34(6): 1111-1118., articleTitle=null, refAbstract=null), Reference(id=1330225377672278679, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=Ghosh S, Durgvanshi S, Agarwal S, et al. Current status of drug targets and emerging therapeutic strategies in the management of Alzheimer's disease[J]. Curr Neuropharmacol, 2020, 18(9): 883-903., articleTitle=null, refAbstract=null), Reference(id=1330225377735193240, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=Nalivaeva NN, Zhuravin IA, Turner AJ. Neprilysin expression and functions in development, ageing and disease[J]. Mech Ageing Dev, 2020, 192: 111363., articleTitle=null, refAbstract=null), Reference(id=1330225377789719193, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=van Dyck CH. Anti-amyloid-β monoclonal antibodies for Alzheimer's disease: pitfalls and promise[J]. Biol Psychiatry, 2018, 83(4): 311-319., articleTitle=null, refAbstract=null), Reference(id=1330225377848439450, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=Chong FP, Ng KY, Koh RY, et al. Tau proteins and tauopathies in Alzheimer's disease[J]. Cell Mol Neurobiol, 2018, 38(5): 965-980., articleTitle=null, refAbstract=null), Reference(id=1330225377911354011, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=Laurent C, Buée L, Blum D. Tau and neuroinflammation: what impact for Alzheimer's disease and tauo pathies?[J]. Biomed J, 2018, 41(1): 21-33., articleTitle=null, refAbstract=null), Reference(id=1330225377982657180, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=Lauretti E, Dincer O, Praticò D. Glycogen synthase kinase-3 signaling in Alzheimer's disease[J]. Biochim Biophys Acta Mol Cell Res, 2020, 1867(5): 118664., articleTitle=null, refAbstract=null), Reference(id=1330225378049766045, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=Fan SJ, Huang FI, Liou JP. The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model[J]. Cell Death Dis, 2018, 9(6): 655., articleTitle=null, refAbstract=null), Reference(id=1330225378137846430, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=Wani WY, Chatham JC, Darley-Usmar V, et al. O-GlcNAcylation and neurodegeneration[J]. Brain Res Bull, 2017, 133: 80-87., articleTitle=null, refAbstract=null), Reference(id=1330225378242704031, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=Hart GW. Nutrient regulation of signaling and transcription[J]. J Biol Chem, 2019, 294(7): 2211-2231., articleTitle=null, refAbstract=null), Reference(id=1330225378309812896, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=Ma X, Li H, He Y, et al. The emerging link between O-GlcNAcylation and neurological disorders[J]. Cell Mol Life Sci, 2017, 74(20): 3667-3686., articleTitle=null, refAbstract=null), Reference(id=1330225378360144545, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=Ng PY, Chang IS, Koh RY. Recent advances in tau-directed immunotherapy against Alzheimer's disease: an overview of pre-clinical and clinical development[J]. Meta Brain Dis, 2020, 35(7): 1049-1066., articleTitle=null, refAbstract=null), Reference(id=1330225378456613538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=Vaz M, Silvestre S. Alzheimer's disease: recent treatment strategies[J]. Eur J Pharmacol, 2020, 887: 173554., articleTitle=null, refAbstract=null), Reference(id=1330225378523722403, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=Novak P, Zilka N, Zilkova M. AADvac1, an active immunotherapy for Alzheimer's disease and non Alzheimer tauopathies: an overview of preclinical and clinical development[J]. J Prev Alzheimers Dis, 2019, 6(1): 63-69., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330225370533573196, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, xref=1., ext=[AuthorCompanyExt(id=1330225370541961805, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370533573196, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225370550350414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370533573196, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1330225370638430799, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, xref=2., ext=[AuthorCompanyExt(id=1330225370646819408, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370638430799, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1330225370651013713, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370638430799, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市生物物质成药性评价技术服务平台,上海 200437)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.04.019, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.04.019, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.04.019, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.04.019, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1649520000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
阿尔茨海默病的药物治疗及研发进展
刘淑青 1, 2 , 顾丰华 1, 2, *
世界临床药物 | 综述评论 2022,43(4): 470-475
收起
收藏切换
世界临床药物 |综述评论 2022 , 43 (4) : 470 -475
阿尔茨海默病的药物治疗及研发进展
全屏
[Author(id=1330225370709733971, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225370797814358, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, authorId=1330225370709733971, language=EN, stringName=Shuqing LIU, firstName=Shuqing, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225370869117527, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, authorId=1330225370709733971, language=CN, stringName=刘淑青, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
2.上海市生物物质成药性评价技术服务平台,上海 200437, bio={"content":"

刘淑青,硕士研究生,研究方向:神经精神药理。

"}, bioImg=null, bioContent=

刘淑青,硕士研究生,研究方向:神经精神药理。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225370533573196, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, xref=1., ext=[AuthorCompanyExt(id=1330225370541961805, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370533573196, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225370550350414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370533573196, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1330225370638430799, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, xref=2., ext=[AuthorCompanyExt(id=1330225370646819408, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370638430799, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1330225370651013713, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370638430799, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市生物物质成药性评价技术服务平台,上海 200437)])]), Author(id=1330225372492313179, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225372592976478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, authorId=1330225372492313179, language=EN, stringName=Fenghua GU, firstName=Fenghua, middleName=null, lastName=GU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225372668473952, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, authorId=1330225372492313179, language=CN, stringName=顾丰华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
2.上海市生物物质成药性评价技术服务平台,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225370533573196, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, xref=1., ext=[AuthorCompanyExt(id=1330225370541961805, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370533573196, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225370550350414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370533573196, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1330225370638430799, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, xref=2., ext=[AuthorCompanyExt(id=1330225370646819408, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370638430799, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1330225370651013713, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225369866678857, companyId=1330225370638430799, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市生物物质成药性评价技术服务平台,上海 200437)])])]
刘淑青1, 2, 顾丰华1, 2, *
作者信息
  • 1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
  • 2.上海市生物物质成药性评价技术服务平台,上海 200437
通讯作者:
顾丰华,副研究员,研究方向:神经精神药理。
作者简介:

刘淑青,硕士研究生,研究方向:神经精神药理。

Drug therapy and research progress of Alzheimer's disease
Shuqing LIU1, 2, Fenghua GU1, 2, *
Affiliations
  • 1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
  • 2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China
出版时间: 2022-04-10 doi: 10.13683/j.wph.2022.04.019
文章导航
收藏切换

阿尔茨海默病(Alzheimer's disease,AD)是一种进行性中枢神经退化性疾病,高发于老年人群。近年来,随着老年人口不断增加,AD患者数量日益增长,其防治迫在眉睫。然而目前临床应用的大多数药物仅能缓解症状,旨在改善病情的药物尚在研发中。该文就现有AD治疗药物和研发现状进行综述,以期为临床治疗提供借鉴。

阿尔茨海默病  /  药物治疗  /  新靶点

Alzheimer's disease (AD) is a progressive central neurodegenerative disease, which is prevalent in the elderly. In recent years, with the increasing elderly population and the increasing number of AD patients, the prevention and treatment of AD is extremely urgent. However, most of the drugs in clinical use can only alleviate symptoms, and drugs aimed at further improvement are being developed. This article reviewed the current status and research and development of AD drugs, in order to provide reference for clinical treatment..

Alzheimer's disease  /  drug treatment  /  the new target
刘淑青, 顾丰华. 阿尔茨海默病的药物治疗及研发进展. 世界临床药物, 2022 , 43 (4) : 470 -475 . DOI: 10.13683/j.wph.2022.04.019
Shuqing LIU, Fenghua GU. Drug therapy and research progress of Alzheimer's disease[J]. World Clinical Drug, 2022 , 43 (4) : 470 -475 . DOI: 10.13683/j.wph.2022.04.019

参考文献 引证文献
排序方式:
[1]
Tezel G, Timur SS, Bozkurt İ, et al. A snapshot on the current status of Alzheimer's disease, treatment perspectives, in-vitro and in-vivo research studies and future opportunities[J]. Chem Pharm Bull (Tokyo), 2019, 67(10): 1030-1041.
[2]
王英全, 梁景宏, 贾瑞霞, 等. 2020—2050年中国阿尔茨海默病患病情况预测研究[J]. 阿尔茨海默病及相关病, 2019, 2(1): 289-298.
[3]
Ramachandran AK, Das S, Joseph A, et al. Neurodegenerative pathways in Alzheimer's disease: a review[J]. Curr Neuropharmacol, 2021, 19(5): 679-692.
[4]
Decker AL, Duncan K. Acetylcholine and the complex interdependence of memory and attention[J]. Curr Opin Behav Sci, 2020, 32(1): 21-28.
[5]
Ghosh S, Jana K, Ganguly B. Revealing the mechanistic pathway of cholinergic inhibition of Alzheimer's disease by donepezil: a metadynamics simulation study[J]. Phys Chem Chem Phys, 2019, 21(25): 13578-13589.
[6]
Wang R, Reddy PH. Role of glutamate and NMDA receptors in Alzheimer's disease[J]. J Alzheimers Dis, 2017, 57(4): 1041-1048.
[7]
Bordji K, Becerril-Ortega J, Buisson A. Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer's disease[J]. Rev Neurosci, 2011, 22(3): 285-294.
[8]
Kishi T. Matsunaga S, Oya K, et al. Memantine for Alzheimer's disease: an updated systematic review and meta-analysis[J]. J Alzheimers Dis, 2017, 60(2): 401-425.
[9]
Newcombe EA, Camats-Perna J, Silva ML, et al. Inflammation: the link between comorbidities, genetics, and Alzheimer's disease[J]. J Neuroinflammation, 2018, 15(1): 276.
[10]
Maphis N, Xu G, Kokiko-Cochran ON, et al. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain[J]. Brain, 2015, 138(Pt 6): 1738-1755.
[11]
Villarejo-Galende A, González-Sánchez M, Blanco-Palmero VA, et al. Non-steroidal anti-inflammatory drugs as candidates for the prevention or treatment of Alzheimer's disease: do they still have a role?[J]. Curr Alzheimer Res, 2020, 17(11): 1013-1022.
[12]
Ozben T, Ozben S. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease[J]. Clin Biochem, 2019, 72: 87-89.
[13]
Cioffi F, Adam RHI, Broersen K. Molecular mechanisms and genetics of oxidative stress in Alzheimer's disease[J]. J Alzheimers Dis, 2019, 72(4): 981-1017.
[14]
Tönnies E, Trushina E. Oxidative stress, synaptic dysfunction, and Alzheimer's disease[J]. J Alzheimers Dis, 2017, 57(4): 1105-1121.
[15]
Ahmad W, Ijaz B, Shabbiri K. Oxidative toxicity in diabetes and Alzheimer's disease: mechanisms behind ROS/RNS generation[J]. J Biomed Sci, 2017, 24(1): 76.
[16]
Schipper HM, Song W, Tavitian A, et al. The sinister face of heme oxygenase-1 in brain aging and disease[J]. Prog Neurobiol, 2019, 172: 40-70.
[17]
Cheignon C, Tomas M, Bonnefont-Rousselot D, et al. Oxidative stress and the amyloid β peptide in Alzheimer's disease[J]. Redox Biol, 2018, 14: 450-464.
[18]
Simunkova M, Alwasel SH, Alhazza IM, et al. Management of oxidative stress and other pathologies in Alzheimer's disease[J]. Arch Toxicol, 2019, 93(9): 2491-2513.
[19]
Daulatzai MA. Pharmacotherpy and Alzheimer's Disease: the M-drugs (melatonin, minocycline, modafinil, and memantine) approach[J]. Curr Pharm Des, 2016, 22(16): 2411-2430.
[20]
Yoo JM, Lee BD, Sok DE, et al. Neuroprotective action of N-acetyl serotonin in oxidative stress-induced apoptosis through the activation of both TrkB/CREB/BDNF pathway and Akt/Nrf2/Antioxidant enzyme in neuronal cells[J]. Redox Biol, 2017, 11: 592-599.
[21]
Uddin MS, Rahma MM, Jakaria M, et al. Estrogen signaling in Alzheimer's disease: molecular insights and therapeutic targets for Alzheimer's dementia[J]. Mol Neurobiol, 2020, 57(6): 2654-2670.
[22]
Scheyer O, Rahman A, Hristov H, et al. Female sex and Alzheimer's risk: the menopause connection[J]. J Prev Alzheimers Dis, 2018, 5(4): 225-230.
[23]
Viña J, Lloret A. Why women have more Alzheimer's disease than men: gender and mitochondrial toxicity of amyloid-β peptide[J]. J Alzheimers Dis, 2010, 20(Suppl 2): S527-S533.
[24]
Bagit A, Hayward GC, MacPherson REK. Exercise and estrogen: common pathways in Alzheimer's disease pathology[J]. Am J Physiol Endocrinol Metab, 2021, 321(1): E164-E168.
[25]
Ding XW, Li R, Geetha T, et al. Nerve growth factor in metabolic complications and Alzheimer's disease: physiology and therapeutic potential[J]. Biochim Biophys Acta Mol Basis Dis, 2020, 1866(10): 165858.
[26]
Mufso EJ, Counts SE, Ginsberg SD, et al. Nerve growth factor pathobiology during the progression of Alzheimer's disease[J]. Front Neurosci, 2019, 13: 533.
[27]
Canu N, Amadoro G, Triaca V, et al. The intersection of NGF/TrkA signaling and amyloid precursor protein processing in Alzheimer's disease neuropathology[J]. Int J Mol Sci, 2017, 18(6): 1319.
[28]
Budni J, Bellettini-Santos T, Mina F, et al. The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease[J]. Aging Dis, 2015, 6(5): 331-341.
[29]
Mitra S, Behbahani H, Eriksdotter M. Innovative therapy for Alzheimer's disease-with focus on biodelivery of NGF[J]. Front Neurosci, 2019, 13: 38.
[30]
Verkhratsky A. Astroglial calcium signaling in aging and Alzheimer's disease[J]. Cold Spring Harb Perspect Biol, 2019, 11(7): a035188.
[31]
Sushma, Mondal AC. Role of GPCR signaling and calcium dysregulation in Alzheimer's disease[J]. Mol Cell Neurosci, 2019, 101: 103414.
[32]
Thuraisingham RA. Pathogenesis of Alzheimer's disease examined using a modified Puri-Li model that incorporates calcium ion homeostasis[J]. J Mol Neurosci, 2018, 65(2): 119-126.
[33]
Verkhratsky A, Rodríguez-Arellano JJ, Parpura V, et al. Astroglial calcium signalling in Alzheimer's disease[J]. Biochem Biophys Res Commun, 2017, 483(4): 1005-1012.
[34]
Popović N, Morales-Delgado N, Mena DV, et al. Verapamil and Alzheimer's disease: past, present, and future[J]. Front Pharmacol, 2020, 11: 562.
[35]
Tadic M, Cuspidi C, Hering D. Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden[J]. Bio Med Central Cardiovascular Disorders, 2016, 16(1): 208.
[36]
Jiang C, Li G, Huang P, et al. The gut microbiota and Alzheimer's disease[J]. J Alzheimers Dis, 2017, 58(1): 1-15.
[37]
Cryan JF, O'Riordan KJ, Cowan CSM, et al. The microbiota-gut-brain axis[J]. Physiol Rev, 2019, 99(4): 1877-2013.
[38]
Angelucci F, Cechova K, Amlerova J, et al. Antibiotics, gut microbiota, and Alzheimer's disease[J]. J Neuroinflammation, 2019, 16(1): 108.
[39]
Wang X, Sun G, Feng T, et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression[J]. Cell Res, 2019, 29(10): 787-803.
[40]
Tiwari S, Atluri V, Kaushik A, et al. Alzheimer's disease: pathogenesis, diagnostics, and therapeutics[J]. Int J Nanomedicine, 2019, 14: 5541-5554.
[41]
Yuan XZ, Sun S, Tan CC, et al. The role of ADAM10 in Alzheimer's disease[J]. J Alzheimers Dis, 2017, 58(2): 303-322.
[42]
Moussa-Pacha NM, Abdin SM, Omar HA, et al. BACE1 inhibitors: current status and future directions in treating Alzheimer's disease[J]. Med Res Rev, 2020, 40(1): 339-384.
[43]
Sun BL, Li WW, Zhu C, et al. Clinical research on Alzheimer's disease: progress and perspectives[J]. Neurosci Bull, 2018, 34(6): 1111-1118.
[44]
Ghosh S, Durgvanshi S, Agarwal S, et al. Current status of drug targets and emerging therapeutic strategies in the management of Alzheimer's disease[J]. Curr Neuropharmacol, 2020, 18(9): 883-903.
[45]
Nalivaeva NN, Zhuravin IA, Turner AJ. Neprilysin expression and functions in development, ageing and disease[J]. Mech Ageing Dev, 2020, 192: 111363.
[46]
van Dyck CH. Anti-amyloid-β monoclonal antibodies for Alzheimer's disease: pitfalls and promise[J]. Biol Psychiatry, 2018, 83(4): 311-319.
[47]
Chong FP, Ng KY, Koh RY, et al. Tau proteins and tauopathies in Alzheimer's disease[J]. Cell Mol Neurobiol, 2018, 38(5): 965-980.
[48]
Laurent C, Buée L, Blum D. Tau and neuroinflammation: what impact for Alzheimer's disease and tauo pathies?[J]. Biomed J, 2018, 41(1): 21-33.
[49]
Lauretti E, Dincer O, Praticò D. Glycogen synthase kinase-3 signaling in Alzheimer's disease[J]. Biochim Biophys Acta Mol Cell Res, 2020, 1867(5): 118664.
[50]
Fan SJ, Huang FI, Liou JP. The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model[J]. Cell Death Dis, 2018, 9(6): 655.
[51]
Wani WY, Chatham JC, Darley-Usmar V, et al. O-GlcNAcylation and neurodegeneration[J]. Brain Res Bull, 2017, 133: 80-87.
[52]
Hart GW. Nutrient regulation of signaling and transcription[J]. J Biol Chem, 2019, 294(7): 2211-2231.
[53]
Ma X, Li H, He Y, et al. The emerging link between O-GlcNAcylation and neurological disorders[J]. Cell Mol Life Sci, 2017, 74(20): 3667-3686.
[54]
Ng PY, Chang IS, Koh RY. Recent advances in tau-directed immunotherapy against Alzheimer's disease: an overview of pre-clinical and clinical development[J]. Meta Brain Dis, 2020, 35(7): 1049-1066.
[55]
Vaz M, Silvestre S. Alzheimer's disease: recent treatment strategies[J]. Eur J Pharmacol, 2020, 887: 173554.
[56]
Novak P, Zilka N, Zilkova M. AADvac1, an active immunotherapy for Alzheimer's disease and non Alzheimer tauopathies: an overview of preclinical and clinical development[J]. J Prev Alzheimers Dis, 2019, 6(1): 63-69.
2022年第43卷第4期
15
5
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2022.04.019
  • 接收时间:2021-06-24
  • 首发时间:2026-11-19
  • 出版时间:2022-04-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2021-06-24
  • 修回日期:2022-02-08
基金
作者信息
    1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
    2.上海市生物物质成药性评价技术服务平台,上海 200437

通讯作者:

顾丰华,副研究员,研究方向:神经精神药理。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.04.019
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏